Delivery Order #SPE2DR26FGP8W

AmerisourceBergen Delivery Order for Xeljanz Tablets under Long-Term Pharmaceutical Contract

This award represents a delivery order contract for pharmaceutical products, specifically Xeljanz 5 mg tablets. The recipient, AmerisourceBergen Drug Corp, known for its extensive pharmaceutical distribution services, is fulfilling this order as part of an ongoing long-term indefinite delivery vehicle (IDV) contract under the Pharmaceutical PV Division. This IDV supports critical healthcare supply chains by ensuring reliable procurement and delivery of essential medications. The scope of this delivery order encompasses supplying a defined quantity of Xeljanz tablets to meet the agency's medical needs. This order was competitively sourced under the existing IDV contract framework that AmerisourceBergen secured for a multi-year period extending over a decade, highlighting the company’s essential role in pharmaceutical provisioning. The order's performance is scheduled over a short timeframe in March 2026 at a designated location in Pennsylvania. This delivery order is a vital component of a substantial agency effort to maintain continuous access to necessary pharmaceuticals and contribute to improved patient care outcomes.

Description

4571079219!XELJANZ 5 MG TABLET UU 60S

View original record